Discover the Dr Reddys Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Dr Reddys Laboratories Ltd is quoting at Rs 1274.9, down 1.2% on the day as on 13:19 IST on the NSE. The stock jumped 2.13% in last one year as compared to a 4.38% slide in NIFTY and a 11.99% spurt in ...

Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter An update from Dr. Reddy’s Laboratories Ltd. ( (IN:DRREDDY)) is now available. Dr.

Dr Reddy’s Laboratories celebrates 25 years on the NYSE by ringing the closing bell, highlighting its commitment to ...

Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem Dr. Reddy's Laboratories (NYSE:RDY) reported what Chief Financial Officer M.V. Narasimham described as a resilient FY 2026 performance ...

Add Yahoo as a preferred source to see more of our stories on Google. SHREVEPORT, La. (KTAL/KMSS) – Dr. Reddy’s Laboratories, a global pharmaceutical company, recently closed in early 2025 due to ...

Dr. Reddy’s Laboratories Ltd. a global pharmaceutical company, today announced the launch of its generic Semaglutide Injection in Canada.

Dr Reddy's Laboratories marked a significant milestone by ringing the closing bell at the New York Stock Exchange, commemorating 25 years since their listing. The ceremony featured company leaders and ...

Dr Reddy’s said the occasion marked 25 years since it became the first pharmaceutical company from Asia outside Japan to be ...

Dr Reddy's Laboratories Limited - Read all the latest news headline updates on Dr Reddy's Laboratories Limited. Get all the Dr Reddy's Laboratories Limited breaking news updates, videos, photostories ...

Dr Reddy's Laboratories reported a 36 per cent increase in its consolidated profit after tax at Rs 1,307 crore for the ...

Dr Reddy’s Laboratories will ring the NYSE Closing Bell to celebrate 25 years since becoming the first Asian pharma company ...